金盾股份(300411.SZ)中標723.40萬元國家電網項目
格隆匯1月8日丨金盾股份(300411.SZ)公佈,公司全資子公司浙江紅相科技股份有限公司(以下簡稱“紅相科技”)於近日收到國家電網有限公司送達的《中標通知書》,確認紅相科技為國家電網有限公司2019年輔助設備、固定資產零購類物資(第二次新增)招標採購貨物包6、包12和包24的中標人。
項目中標總額為723.40萬元,佔紅相科技2018年度經審計營業收入的3.12%,中標項目簽訂正式合同並順利實施後,有利於加深紅相科技產品對市場的影響力,預計對公司未來的經營業績產生一定的積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.